Geode Capital Management’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.98B Sell
5,093,882
-72,833
-1% -$28.3M 0.14% 120
2025
Q1
$2.25B Buy
5,166,715
+202,724
+4% +$88.1M 0.18% 100
2024
Q4
$1.83B Buy
4,963,991
+115,971
+2% +$42.7M 0.14% 113
2024
Q3
$2.51B Buy
4,848,020
+85,770
+2% +$44.4M 0.2% 81
2024
Q2
$2.57B Buy
4,762,250
+67,365
+1% +$36.4M 0.23% 74
2024
Q1
$2.43B Buy
4,694,885
+177,156
+4% +$91.6M 0.22% 75
2023
Q4
$2.12B Buy
4,517,729
+97,290
+2% +$45.8M 0.22% 80
2023
Q3
$1.92B Buy
4,420,439
+78,981
+2% +$34.3M 0.23% 78
2023
Q2
$1.92B Buy
4,341,458
+63,121
+1% +$28M 0.23% 80
2023
Q1
$1.96B Buy
4,278,337
+59,126
+1% +$27.1M 0.25% 76
2022
Q4
$2.16B Buy
4,219,211
+12,281
+0.3% +$6.29M 0.3% 63
2022
Q3
$1.91B Buy
4,206,930
+75,103
+2% +$34.1M 0.29% 61
2022
Q2
$1.99B Buy
4,131,827
+135,789
+3% +$65.4M 0.29% 62
2022
Q1
$1.96B Sell
3,996,038
-178,540
-4% -$87.5M 0.24% 71
2021
Q4
$1.93B Buy
4,174,578
+51,641
+1% +$23.9M 0.23% 78
2021
Q3
$1.53B Buy
4,122,937
+161,927
+4% +$60.2M 0.21% 87
2021
Q2
$1.51B Buy
3,961,010
+171,787
+5% +$65.4M 0.21% 89
2021
Q1
$1.36B Buy
3,789,223
+60,325
+2% +$21.6M 0.21% 86
2020
Q4
$1.19B Sell
3,728,898
-4,486
-0.1% -$1.44M 0.2% 93
2020
Q3
$1B Sell
3,733,384
-43,784
-1% -$11.7M 0.2% 92
2020
Q2
$992M Buy
3,777,168
+58,127
+2% +$15.3M 0.21% 87
2020
Q1
$843M Sell
3,719,041
-3,688
-0.1% -$836K 0.22% 93
2019
Q4
$1.12B Buy
3,722,729
+181,091
+5% +$54.6M 0.23% 78
2019
Q3
$849M Sell
3,541,638
-62,213
-2% -$14.9M 0.2% 95
2019
Q2
$1.02B Sell
3,603,851
-24,523
-0.7% -$6.91M 0.25% 76
2019
Q1
$1.04B Buy
3,628,374
+240,749
+7% +$69M 0.27% 71
2018
Q4
$888M Buy
3,387,625
+273,738
+9% +$71.8M 0.27% 71
2018
Q3
$852M Buy
3,113,887
+88,557
+3% +$24.2M 0.24% 78
2018
Q2
$719M Buy
3,025,330
+94,633
+3% +$22.5M 0.22% 82
2018
Q1
$642M Buy
2,930,697
+66,673
+2% +$14.6M 0.21% 93
2017
Q4
$643M Buy
2,864,024
+51,003
+2% +$11.5M 0.22% 88
2017
Q3
$533M Buy
2,813,021
+83,238
+3% +$15.8M 0.2% 98
2017
Q2
$513M Buy
2,729,783
+35,362
+1% +$6.64M 0.2% 95
2017
Q1
$445M Buy
2,694,421
+206,900
+8% +$34.2M 0.18% 111
2016
Q4
$357M Buy
2,487,521
+114,058
+5% +$16.4M 0.17% 119
2016
Q3
$297M Buy
2,373,463
+104,535
+5% +$13.1M 0.15% 134
2016
Q2
$298M Buy
2,268,928
+27,382
+1% +$3.59M 0.16% 120
2016
Q1
$311K Buy
2,241,546
+43,732
+2% +$6.07K 0.17% 118
2015
Q4
$306M Buy
2,197,814
+29,570
+1% +$4.12M 0.17% 114
2015
Q3
$303M Buy
2,168,244
+10,263
+0.5% +$1.43M 0.18% 109
2015
Q2
$354M Sell
2,157,981
-33,375
-2% -$5.47M 0.2% 102
2015
Q1
$338M Buy
2,191,356
+63,440
+3% +$9.78M 0.19% 103
2014
Q4
$267M Buy
2,127,916
+44,132
+2% +$5.54M 0.16% 127
2014
Q3
$249M Sell
2,083,784
-48,463
-2% -$5.79M 0.16% 127
2014
Q2
$229M Sell
2,132,247
-40,375
-2% -$4.34M 0.15% 143
2014
Q1
$216M Sell
2,172,622
-49,227
-2% -$4.9M 0.15% 145
2013
Q4
$205M Buy
2,221,849
+121,931
+6% +$11.3M 0.14% 144
2013
Q3
$176M Buy
2,099,918
+45,490
+2% +$3.8M 0.14% 143
2013
Q2
$168M Buy
+2,054,428
New +$168M 0.15% 133